{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:11:31Z","timestamp":1789456291353,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Center for Research in FOP and Related Disorders"},{"name":"Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine"},{"name":"Robert and Arlene Professorship in Geriatric Medicine"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bone.2017.12.011","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:58:48Z","timestamp":1513018728000},"page":"281-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases"],"prefix":"10.1016","volume":"109","author":[{"given":"Frederick S.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Benor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Al Mukaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.12.011_bb0005","series-title":"Emerging Concepts in Pediatric Bone Disease","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons","volume":"10(S-2)","author":"Pignolo","year":"2013"},{"key":"10.1016\/j.bone.2017.12.011_bb0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva: a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.011_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.12.011_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bone.2017.12.011_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000324230","article-title":"In vitro analysis of dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP","volume":"194","author":"Groppe","year":"2011","journal-title":"Cells Tissues Organs"},{"issue":"11","key":"10.1016\/j.bone.2017.12.011_bb0030","first-page":"3462","article-title":"The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization","volume":"119","author":"Shen","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.12.011_bb0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cytogfr.2009.10.006","article-title":"The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling","volume":"20","author":"Kaplan","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"issue":"303","key":"10.1016\/j.bone.2017.12.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1(R206H) receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2005","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2017.12.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","author":"Hino","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bone.2017.12.011_bb0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcdb.2015.12.013","article-title":"Granting immunity to FOP and catching heterotopic ossification in the act","volume":"49","author":"Kaplan","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bone.2017.12.011_bb0055","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.12.011_bb0060","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1073\/pnas.1515397113","article-title":"Inhibition of Hif1\u03b1 prevents both trauma-induced and genetic heterotopic ossification","volume":"113","author":"Agarwal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.12.011_bb0065","series-title":"The Medical Management of Fibrodysplasia Ossificans Progressiva: Current Treatment Considerations","first-page":"1","volume":"4","year":"2011"},{"key":"10.1016\/j.bone.2017.12.011_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/21678707.2017.1304211","article-title":"Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)","volume":"5","author":"Kaplan","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.bone.2017.12.011_bb0075","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMcibr1709384","article-title":"Game of TOR\u2014the target of rapamycin rules four kingdoms","volume":"377","author":"Manning","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.bone.2017.12.011_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89805","article-title":"mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regeneration","volume":"1","author":"Agarwal","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bone.2017.12.011_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/JCI93521","article-title":"Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva","author":"Hino","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2017.12.011_bb0090","article-title":"Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling","author":"Jiang","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.bone.2017.12.011_bb0095","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.ajpath.2017.07.010","article-title":"Inhibition of mammalian target of rapamycin signaling with rapamycin prevents trauma-induced heterotopic ossification","volume":"187","author":"Qureshi","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2017.12.011_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bone.2017.04.015","article-title":"A cumulative analogue joint involvement scale for fibrodysplasia ossificans progressiva (FOP)","volume":"101","author":"Kaplan","year":"2017","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T15:35:16Z","timestamp":1532532916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217304520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":20,"alternative-id":["S8756328217304520"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}